A股異動丨德賽電池(000049.SZ)漲停 子公司擬通過增資方式引入戰投
格隆匯12月23日丨德賽電池(000049.SZ)高開直線漲停,報57.82元,暫成交2.07億元,總市值119.8億元。德賽電池22日公告,公司正籌劃有關全資子公司惠州電池通過增資方式引入戰略投資者的重大資產重組事項。22日公司與香港新能達簽署了《重組意向書》,擬由香港新能達以其持有的東莞新能德全部股權作價對惠州電池增資,增資完成後,香港新能達持有惠州電池不超過49%的股權。德賽電池認為,本次交易的目的是為了促進公司的可持續發展,符合公司整體發展戰略。不過,本次簽署的《重組意向書》對公司2020年度經營業績不會產生重大影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.